Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families.
about
Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic parameters in patients with pulmonary arterial hypertension.BRCA Share: A Collection of Clinical BRCA Gene Variants.Adding In Silico Assessment of Potential Splice Aberration to the Integrated Evaluation of BRCA Gene Unclassified Variants.Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples.Characterization of BRCA1 and BRCA2 variants found in a Norwegian breast or ovarian cancer cohort.Combined annotation-dependent depletion score for BRCA1/2 variants in patients with breast and/or ovarian cancer.Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.The role of targeted BRCA1/BRCA2 mutation analysis in hereditary breast/ovarian cancer families of Portuguese ancestry.
P2860
Q33769113-8F2959BF-83BC-4CB9-9E5B-A50B23BE1396Q39384483-D04BF863-37DE-419A-9C9B-8CC6BCDF19D3Q39969865-8ECB91D9-0CF9-4311-8F1C-F7D64DF69375Q47777780-B039E4D0-C103-4B42-BE18-237B44273663Q48124777-28B6184B-A984-48AB-BE96-B750E7472E57Q48159694-5246D66E-A9C2-421B-8CD5-22FD0CFAAE19Q49097031-9CCB2818-6264-4F7F-9979-7C907E58A0A9Q49817640-F91CD2B8-76DA-4A90-878B-39238164CFEBQ51075493-94CD632D-7540-4E4D-A9F5-82E04CE2D485
P2860
Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Pathogenicity evaluation of BR ...... reast/ovarian cancer families.
@en
Pathogenicity evaluation of BR ...... reast/ovarian cancer families.
@nl
type
label
Pathogenicity evaluation of BR ...... reast/ovarian cancer families.
@en
Pathogenicity evaluation of BR ...... reast/ovarian cancer families.
@nl
prefLabel
Pathogenicity evaluation of BR ...... reast/ovarian cancer families.
@en
Pathogenicity evaluation of BR ...... reast/ovarian cancer families.
@nl
P50
P1476
Pathogenicity evaluation of BR ...... reast/ovarian cancer families.
@en
P2093
Susana Bizarro
P304
P356
10.1016/J.JMOLDX.2014.01.005
P407
P50
P577
2014-03-05T00:00:00Z